(IN BRIEF) A new University of Southampton–led human challenge trial has shown that BPZE1, a nasal spray vaccine for whooping cough, can prevent the bacteria from colonising the nose and throat — a first for any whooping cough vaccine. Conducted … Read the full press release
Posted in Business, Education, Environment, Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Ashley Dalton, BPZE1, clinical trial, controlled infection model, Diane Gbesemete, human challenge trial, ILiAD Biotechnologies, Marian Knight, nasal spray vaccine, NIHR, NIHR Southampton BRC, NIHR Southampton CRF, PERISCOPE consortium, pertussis, public health, respiratory infections, Robert Read, The Lancet Microbe, UKHSA, University Hospital Southampton, University of Oxford, University of Southampton, University of Southampton research demonstrates strong protection from BPZE1 nasal vaccine against whooping cough spread, vaccine, whooping cough
SOUTHAMPTON, 02-Feb-2018 — /EuropaWire/ — The University of Southampton is delighted to announce it has reached its £25m target to fund the UK’s first dedicated centre for cancer immunology research. For decades, Southampton scientists have made a number of advances … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged cancer immunology research, Centre for Cancer Immunology, immunology, Patricia Marriott, Professor Sir Christopher Snowden, Professor Tim Elliott, The University of Southampton, University Hospital Southampton
SOUTHAMPTON, 25-Jul-2017 — /EuropaWire/ — International rock sensations Coldplay have donated to the University of Southampton’s campaign for the Centre for Cancer Immunology. The band chose the campaign through the close links drummer Will Champion has with both Southampton and the … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?